Skip to main content

Advertisement

SpringerLink
Log in

The Pan-Cancer Atlas: a New Chapter in Cancer Molecular Targeting Therapy

  • Letter to the Editor
  • Published:
Pathology & Oncology Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sticz T, Molnar A, Danko T et al (2018) The effects of different mTOR inhibitors in EGFR inhibitor resistant Colon carcinoma cells. Pathol. Oncol. Res: POR. https://doi.org/10.1007/s12253-018-0434-4

  2. Evans M, O'Sullivan B, Hughes F et al (2018) The Clinicopathological and molecular associations of PD-L1 expression in non-small cell lung Cancer: analysis of a series of 10,005 cases tested with the 22C3 assay. Pathol. Oncol. Res: POR. https://doi.org/10.1007/s12253-018-0469-6

  3. Cancer Genome Atlas Research N, Analysis Working Group, Genome Sequencing Center et al (2017) Integrated genomic characterization of oesophageal carcinoma. Nature 541(7636):169–175. https://doi.org/10.1038/nature20805

    Article  CAS  Google Scholar 

  4. Hoadley KA, Yau C, Hinoue T et al (2018) Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of Cancer. Cell 173(2):291–304 e296. https://doi.org/10.1016/j.cell.2018.03.022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ding L, Bailey MH, Porta-Pardo E et al (2018) Perspective on oncogenic processes at the end of the beginning of Cancer genomics. Cell 173(2):305–320 e310. https://doi.org/10.1016/j.cell.2018.03.033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sanchez-Vega F, Mina M, Armenia J et al (2018) Oncogenic signaling pathways in the Cancer Genome Atlas. Cell 173(2):321–337 e310. https://doi.org/10.1016/j.cell.2018.03.035

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Liu Y, Sethi NS, Hinoue T et al (2018) Comparative molecular analysis of gastrointestinal adenocarcinomas. Cancer Cell 33(4):721–735 e728. https://doi.org/10.1016/j.ccell.2018.03.010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Berger AC, Korkut A, Kanchi RS et al (2018) A comprehensive pan-Cancer molecular study of gynecologic and breast cancers. Cancer Cell 33(4):690–705 e699. https://doi.org/10.1016/j.ccell.2018.03.014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Campbell JD, Yau C, Bowlby R et al (2018) Genomic, pathway network, and immunologic features distinguishing squamous carcinomas. Cell Rep 23(1):194–212 e196. https://doi.org/10.1016/j.celrep.2018.03.063

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ricketts CJ, De Cubas AA, Fan H et al (2018) The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep 23(1):313–326 e315. https://doi.org/10.1016/j.celrep.2018.03.075

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Taylor AM, Shih J, Ha G et al (2018) Genomic and functional approaches to understanding Cancer aneuploidy. Cancer Cell 33(4):676–689 e673. https://doi.org/10.1016/j.ccell.2018.03.007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Jayasinghe RG, Cao S, Gao Q et al (2018) Systematic analysis of splice-site-creating mutations in Cancer. Cell Rep 23(1):270–281 e273. https://doi.org/10.1016/j.celrep.2018.03.052

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Seiler M, Peng S, Agrawal AA et al (2018) Somatic mutational landscape of splicing factor genes and their functional consequences across 33 Cancer types. Cell Rep 23(1):282–296 e284. https://doi.org/10.1016/j.celrep.2018.01.088

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Huang KL, Mashl RJ, Wu Y et al (2018) Pathogenic germline variants in 10,389 adult cancers. Cell 173(2):355–370 e314. https://doi.org/10.1016/j.cell.2018.03.039

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cilloni D, Saglio G (2012) Molecular pathways: BCR-ABL. Clinical Cancer Research : an official journal of the American Association for Cancer Research 18(4):930–937. https://doi.org/10.1158/1078-0432.CCR-10-1613

    Article  CAS  Google Scholar 

  16. Gao Q, Liang WW, Foltz SM et al (2018) Driver fusions and their implications in the development and treatment of human cancers. Cell Rep 23(1):227–238 e223. https://doi.org/10.1016/j.celrep.2018.03.050

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Cancer Genome Atlas N (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517(7536):576–582. https://doi.org/10.1038/nature14129

    Article  CAS  Google Scholar 

  18. Laroche-Clary A, Chaire V, Algeo MP et al (2017) Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas. J Hematol Oncol 10(1):123. https://doi.org/10.1186/s13045-017-0482-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Hao-Liang Hu and Dan-Dan Zeng wrote this letter; Jing-Lei Zang and Zhe Chen revised the letter. This work was supported by the Teaching Reform Research Project for Colleges and Universities of Hunan Province (No. (2018) 436-974).

Author information

Authors and Affiliations

  1. College of Life Sciences, Hunan Normal University, Changsha, 410006, China

    Hao-Liang Hu, Dan-Dan Zeng & Jing-Lei Zang

  2. Department of Pharmacy, Changsha Health Vocational College, Changsha, 410006, China

    Jing-Lei Zang

  3. Nursing College, Hunan Institute Of Traffic Engineering, Hengyang, 421001, China

    Zhe Chen

Authors
  1. Hao-Liang Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dan-Dan Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jing-Lei Zang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhe Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jing-Lei Zang or Zhe Chen.

Ethics declarations

Conflict of Interest

The authors declare no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, HL., Zeng, DD., Zang, JL. et al. The Pan-Cancer Atlas: a New Chapter in Cancer Molecular Targeting Therapy. Pathol. Oncol. Res. 26, 1997–1999 (2020). https://doi.org/10.1007/s12253-019-00709-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-019-00709-x

Search

Navigation